Invexans S.A. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was USD 1,025.43 million compared to USD 593.31 million a year ago. Net income was USD 18.44 million compared to net loss of USD 6.02 million a year ago. Basic earnings per share from continuing operations was USD 0.0004. Diluted earnings per share from continuing operations was USD 0.0004. For the nine months, sales was USD 2,695.08 million compared to USD 1,132.05 million a year ago. Net income was USD 90.03 million compared to net loss of USD 42.37 million a year ago. Basic earnings per share from continuing operations was USD 0.0018 compared to basic loss per share from continuing operations of USD 0.0011 a year ago. Diluted earnings per share from continuing operations was USD 0.0018 compared to diluted loss per share from continuing operations of USD 0.0011 a year ago.